Brind.
  1. Marty Jackley, who serves as the South Dakota Attorney General, is investigating nationwide fraud issues.
  2. Bills governing state policy and technology use were introduced in South Dakota.

South Dakota to Assess New Federal Drug Pricing Model for Medicaid Program

1 report, 1 independent Updated Sep 22
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

A new federal pricing model was announced at the White House that could impact state policy issues in South Dakota. The voluntary program, which aims to lower Medicaid drug costs, ties prices to those paid in certain other countries. South Dakota has identified three medications that could qualify for the program, which could save the state an estimated $750,000 annually on prescription drugs.

From ktiv.com

Why it matters

Some supportBrind's analysis of the reports

The model, called the GENEROUS Model, is designed to reduce Medicaid drug spending while aligning prices with international rates. The state must finalize participation agreements regarding the model by September 30.

Bills governing state policy and technology use were introduced in South Dakota. Marty Jackley, who serves as the South Dakota Attorney General, is investigating nationwide fraud issues.

From ktiv.com

Who's involved

  • South DakotaState considering the voluntary federal pricing model to reduce Medicaid drug expenditures.

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped